| Metric | Q4 FY26 | Q3 FY26 | Q4 FY25 |
|---|---|---|---|
| Revenue from operations | 1100.8 | 1106.2 | 1046.4 |
| Other income | 46.6 | 15.9 | 37.1 |
| Total income | 1147.4 | 1122.1 | 1083.5 |
| Profit before exceptional items & tax | 206.4 | 113.0 | 167.9 |
| Profit before tax | 206.4 | 113.0 | 167.9 |
| Net profit | 162.1 | 95.7 | 143.3 |
| Operating margin | 18.0% | 10.1% | 15.5% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | +13.10% |
|---|---|
| Net profit, quarter on quarter | +69.40% |
| Revenue, year on year | +5.20% |
BSE results filing, NSE: BAYERCROP. Figures extracted from the filing.
Bayer Cropscience Ltd: key numbers
- Share price
- ₹3,533.40
- Market cap
- ₹15,880 Cr
- Revenue (annual)
- ₹5,675 Cr
- Net profit (annual)
- ₹689.2 Cr
- P/E (TTM)
- 21.7×Sector 37.2×
- Promoter holding
- 71.43%+0.00% QoQ
- FII holding
- 3.97%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Bayer Cropscience Ltd
All →Bayer Cropscience Other Announcement
Bayer CropScience Limited has announced the closure of its trading window for designated persons, effective from October 1, 2026, until November 16, 2026.
Bayer Cropscience Annual General Meeting
Bayer CropScience seeks member approval via postal ballot to appoint Mr. Ravi Kirpalani as Independent Director for five years. Voting window: September 14 to October 13, 2026.
Bayer Cropscience Other Announcement
Bayer CropScience Ltd has been assigned an ESG rating of 'Crisil ESG 66' and 'Crisil Core ESG 70' by Crisil ESG Ratings and Analytics Limited.
Bayer Cropscience Annual General Meeting
Bayer CropScience held its 68th Annual General Meeting on August 19, 2026. Shareholders approved all resolutions, including final dividend declaration and material related party transactions.
Bayer Cropscience Results Update
Bayer CropScience reported Q1 FY2026-27 revenue of ₹1,835 Crore and Profit Before Tax of ₹402.1 Crore. Management highlighted resilient performance amid challenging weather and market conditions.
Bayer Cropscience Management Change
Bayer CropScience Ltd announced the appointment of Mr. Ravi Moti Kirpalani as an Additional Independent Director and Chairman, succeeding Mr. Pankaj Ramanbhai Patel.